potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide

C139H160BBr3KN19O20S2 — CID 163665953

IUPACpotassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide
SMILESC.C.C.C.CN1CCN(CCOc2ccc(-c3ccc4nc(-c5cn(C)c(=O)c6[nH]ccc56)ccc4c3)cc2)CC1=O.CN1CCN(CCOc2ccc(B3OC(C)(C)C(C)(C)O3)cc2)CC1=O.CN1CCN(CCOc2ccc(Br)cc2)CC1=O.Cc1ccc(S(=O)(=O)n2ccc3c(-c4ccc5cc(-c6ccc(OCCN7CCN(C)C(=O)C7)cc6)ccc5n4)cn(C)c(=O)c32)cc1.Cc1ccc(S(=O)(=O)n2ccc3c(-c4ccc5cc(Br)ccc5n4)cn(C)c(=O)c32)cc1.O=C1CN(CCOc2ccc(Br)cc2)CCN1.[K+].[OH-]
InChIInChI=1S/C37H35N5O5S.C30H29N5O3.C24H18BrN3O3S.C19H29BN2O4.C13H17BrN2O2.C12H15BrN2O2.4CH4.K.H2O/c1-25-4-12-30(13-5-25)48(45,46)42-17-16-31-32(23-40(3)37(44)36(31)42)34-15-9-28-22-27(8-14-33(28)38-34)26-6-10-29(11-7-26)47-21-20-41-19-18-39(2)35(43)24-41;1-33-13-14-35(19-28(33)36)15-16-38-23-7-3-20(4-8-23)21-5-9-26-22(17-21)6-10-27(32-26)25-18-34(2)30(37)29-24(25)11-12-31-29;1-15-3-7-18(8-4-15)32(30,31)28-12-11-19-20(14-27(2)24(29)23(19)28)22-9-5-16-13-17(25)6-10-21(16)26-22;1-18(2)19(3,4)26-20(25-18)15-6-8-16(9-7-15)24-13-12-22-11-10-21(5)17(23)14-22;1-15-6-7-16(10-13(15)17)8-9-18-12-4-2-11(14)3-5-12;13-10-1-3-11(4-2-10)17-8-7-15-6-5-14-12(16)9-15;;;;;;/h4-17,22-23H,18-21,24H2,1-3H3;3-12,17-18,31H,13-16,19H2,1-2H3;3-14H,1-2H3;6-9H,10-14H2,1-5H3;2-5H,6-10H2,1H3;1-4H,5-9H2,(H,14,16);4*1H4;;1H2/q;;;;;;;;;;+1;/p-1
InChIKeyIYLNLQURLHDZIZ-UHFFFAOYSA-M
MW2770.68 g/mol
LogP17.06
Rot. Bonds30

About potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide

potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide (PubChem CID 163665953) has the molecular formula C139H160BBr3KN19O20S2 and a molecular weight of 2770.68 g/mol. Its IUPAC name is potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide.

Molecular Properties

Compound Namepotassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide
PubChem CID163665953
Molecular FormulaC139H160BBr3KN19O20S2
Molecular Weight2770.68 g/mol
Exact Mass2765.88
IUPAC Namepotassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide
SMILESC.C.C.C.CN1CCN(CCOc2ccc(-c3ccc4nc(-c5cn(C)c(=O)c6[nH]ccc56)ccc4c3)cc2)CC1=O.CN1CCN(CCOc2ccc(B3OC(C)(C)C(C)(C)O3)cc2)CC1=O.CN1CCN(CCOc2ccc(Br)cc2)CC1=O.Cc1ccc(S(=O)(=O)n2ccc3c(-c4ccc5cc(-c6ccc(OCCN7CCN(C)C(=O)C7)cc6)ccc5n4)cn(C)c(=O)c32)cc1.Cc1ccc(S(=O)(=O)n2ccc3c(-c4ccc5cc(Br)ccc5n4)cn(C)c(=O)c32)cc1.O=C1CN(CCOc2ccc(Br)cc2)CCN1.[K+].[OH-]
InChIInChI=1S/C37H35N5O5S.C30H29N5O3.C24H18BrN3O3S.C19H29BN2O4.C13H17BrN2O2.C12H15BrN2O2.4CH4.K.H2O/c1-25-4-12-30(13-5-25)48(45,46)42-17-16-31-32(23-40(3)37(44)36(31)42)34-15-9-28-22-27(8-14-33(28)38-34)26-6-10-29(11-7-26)47-21-20-41-19-18-39(2)35(43)24-41;1-33-13-14-35(19-28(33)36)15-16-38-23-7-3-20(4-8-23)21-5-9-26-22(17-21)6-10-27(32-26)25-18-34(2)30(37)29-24(25)11-12-31-29;1-15-3-7-18(8-4-15)32(30,31)28-12-11-19-20(14-27(2)24(29)23(19)28)22-9-5-16-13-17(25)6-10-21(16)26-22;1-18(2)19(3,4)26-20(25-18)15-6-8-16(9-7-15)24-13-12-22-11-10-21(5)17(23)14-22;1-15-6-7-16(10-13(15)17)8-9-18-12-4-2-11(14)3-5-12;13-10-1-3-11(4-2-10)17-8-7-15-6-5-14-12(16)9-15;;;;;;/h4-17,22-23H,18-21,24H2,1-3H3;3-12,17-18,31H,13-16,19H2,1-2H3;3-14H,1-2H3;6-9H,10-14H2,1-5H3;2-5H,6-10H2,1H3;1-4H,5-9H2,(H,14,16);4*1H4;;1H2/q;;;;;;;;;;+1;/p-1
InChIKeyIYLNLQURLHDZIZ-UHFFFAOYSA-M
XLogP17.06
TPSA419.75 Ų
H-Bond Donors2
H-Bond Acceptors33
Rotatable Bonds30
Heavy Atoms185
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002770.68
LogP ≤ 517.06
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide?
The IUPAC name of potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide (CID 163665953) is potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide.
What is the SMILES notation for potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide?
The canonical SMILES for potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide is C.C.C.C.CN1CCN(CCOc2ccc(-c3ccc4nc(-c5cn(C)c(=O)c6[nH]ccc56)ccc4c3)cc2)CC1=O.CN1CCN(CCOc2ccc(B3OC(C)(C)C(C)(C)O3)cc2)CC1=O.CN1CCN(CCOc2ccc(Br)cc2)CC1=O.Cc1ccc(S(=O)(=O)n2ccc3c(-c4ccc5cc(-c6ccc(OCCN7CCN(C)C(=O)C7)cc6)ccc5n4)cn(C)c(=O)c32)cc1.Cc1ccc(S(=O)(=O)n2ccc3c(-c4ccc5cc(Br)ccc5n4)cn(C)c(=O)c32)cc1.O=C1CN(CCOc2ccc(Br)cc2)CCN1.[K+].[OH-].
What is the InChIKey of potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide?
The InChIKey is IYLNLQURLHDZIZ-UHFFFAOYSA-M. The full InChI is InChI=1S/C37H35N5O5S.C30H29N5O3.C24H18BrN3O3S.C19H29BN2O4.C13H17BrN2O2.C12H15BrN2O2.4CH4.K.H2O/c1-25-4-12-30(13-5-25)48(45,46)42-17-16-31-32(23-40(3)37(44)36(31)42)34-15-9-28-22-27(8-14-33(28)38-34)26-6-10-29(11-7-26)47-21-20-41-19-18-39(2)35(43)24-41;1-33-13-14-35(19-28(33)36)15-16-38-23-7-3-20(4-8-23)21-5-9-26-22(17-21)6-10-27(32-26)25-18-34(2)30(37)29-24(25)11-12-31-29;1-15-3-7-18(8-4-15)32(30,31)28-12-11-19-20(14-27(2)24(29)23(19)28)22-9-5-16-13-17(25)6-10-21(16)26-22;1-18(2)19(3,4)26-20(25-18)15-6-8-16(9-7-15)24-13-12-22-11-10-21(5)17(23)14-22;1-15-6-7-16(10-13(15)17)8-9-18-12-4-2-11(14)3-5-12;13-10-1-3-11(4-2-10)17-8-7-15-6-5-14-12(16)9-15;;;;;;/h4-17,22-23H,18-21,24H2,1-3H3;3-12,17-18,31H,13-16,19H2,1-2H3;3-14H,1-2H3;6-9H,10-14H2,1-5H3;2-5H,6-10H2,1H3;1-4H,5-9H2,(H,14,16);4*1H4;;1H2/q;;;;;;;;;;+1;/p-1.
What are the key properties of potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide?
potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide has a molecular weight of 2770.68 g/mol, XLogP of 17.06, 30 rotatable bonds, 2 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for potassium;4-[2-(4-bromophenoxy)ethyl]-1-methylpiperazin-2-one;4-[2-(4-bromophenoxy)ethyl]piperazin-2-one;4-(6-bromoquinolin-2-yl)-6-methyl-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;methane;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-c]pyridin-7-one;6-methyl-4-[6-[4-[2-(4-methyl-3-oxopiperazin-1-yl)ethoxy]phenyl]quinolin-2-yl]-1H-pyrrolo[2,3-c]pyridin-7-one;1-methyl-4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]piperazin-2-one;hydroxide is sourced from PubChem (CID 163665953), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).